Search Results

Facet (Page)

Refine Your Search
Audiences
Content Formats
Sections
Divisions
1 - 3 of 3
Policy Issues
Intellectual Property in Genomics
In June 2013, the Supreme Court determined that DNA in its natural form cannot be patented.
… suit challenged the constitutionality and validity of the BRCA1 and BRCA2 gene patents. Myriad Genetics had been … plaintiffs  and against Myriad Genetics, finding that the BRCA1 and BRCA2 genes were products of nature and therefore …
Policy Issues
La propiedad intelectual y la genómica
En una decisión histórica en junio de 2013, el Tribunal Supremo determinó que el ADN en su forma natural no puede ser patentado.
… la constitucionalidad y validez de las patentes génicas de BRCA1 y BRCA2. Myriad Genetics había sido especialmente … en contra de Myriad Genetics, determinando que los genes BRCA1 y BRCA2 eran productos de la naturaleza y, por ende, no …
About NHGRI
NHGRI History and Timeline of Events
A timeline of notable events in the history of the National Human Genome Research Institute.
… that three specific alterations in the breast cancer genes BRCA1 and BRCA2 are associated with an increased risk of …